Form 4: CONMED Corp Executive Granted Stock Options

Andrew James Moller, VP Corporate Controller at CONMED Corp, was granted 5,000 stock options on January 27, 2025, under the company's 2018 Long-Term Incentive Plan.

Summary

• Andrew James Moller, VP Corporate Controller at CONMED Corp, received 5,000 stock options on January 27, 2025.
• These options were granted under the company's 2018 Long-Term Incentive Plan.
• The options have an exercise price of $71.18.
• The options vest in equal amounts over a five-year period.
• The options expire on January 27, 2035.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management with shareholder interests. There are no negative implications.

Positives

• The grant of stock options aligns the executive's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.

Industry Context

Stock option grants are a common practice in corporate compensation, particularly for executives, to incentivize performance and align their interests with shareholders.

Comparison to Industry Standards

• Stock option grants are a standard component of executive compensation packages across various industries.
• The vesting period of five years is also a common practice to ensure long-term commitment.
• The specific terms of the grant, such as the exercise price and vesting schedule, are typical for companies of CONMED's size and industry.

Stakeholder Impact

• The stock option grant may have a positive impact on shareholders by aligning executive interests with company performance.
• The grant may also positively impact the executive by providing a long-term incentive.

Key Dates

Keywords

stock options, executive compensation, insider trading, CONMED Corp, incentive plan, equity